The effectiveness of Abraxane has been studied in one main study involving 460 women with metastatic breast cancer, around three-quarters of whom had received an anthracycline in the past.
Abraxane efektiivsust uuriti ühes põhiuuringus, milles osales 460 metastaatilise rinnavähiga naist, kellest ligikaudu kolm neljandikku olid varem saanud antratsükliini.